- Home
- KTTA vs GRABW Comparison
KTTA vs GRABW Comparison
Compare KTTA & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- GRABW
- Stock Information
- Founded
- KTTA 2020
- GRABW 2012
- Country
- KTTA United States
- GRABW Singapore
- Employees
- KTTA N/A
- GRABW 11267
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- GRABW Business Services
- Sector
- KTTA Health Care
- GRABW Consumer Discretionary
- Exchange
- KTTA Nasdaq
- GRABW Nasdaq
- Market Cap
- KTTA 5.1M
- GRABW N/A
- IPO Year
- KTTA 2021
- GRABW N/A
- Fundamental
- Price
- KTTA $0.72
- GRABW $0.49
- Analyst Decision
- KTTA
- GRABW
- Analyst Count
- KTTA 0
- GRABW 0
- Target Price
- KTTA N/A
- GRABW N/A
- AVG Volume (30 Days)
- KTTA 201.4K
- GRABW 54.7K
- Earning Date
- KTTA 11-12-2025
- GRABW 02-21-2025
- Dividend Yield
- KTTA N/A
- GRABW N/A
- EPS Growth
- KTTA N/A
- GRABW N/A
- EPS
- KTTA N/A
- GRABW N/A
- Revenue
- KTTA N/A
- GRABW $2,686,000,000.00
- Revenue This Year
- KTTA N/A
- GRABW N/A
- Revenue Next Year
- KTTA N/A
- GRABW N/A
- P/E Ratio
- KTTA N/A
- GRABW N/A
- Revenue Growth
- KTTA N/A
- GRABW 21.65
- 52 Week Low
- KTTA $0.65
- GRABW $0.15
- 52 Week High
- KTTA $7.50
- GRABW $0.59
- Technical
- Relative Strength Index (RSI)
- KTTA 43.23
- GRABW 66.31
- Support Level
- KTTA $0.74
- GRABW $0.43
- Resistance Level
- KTTA $0.81
- GRABW $0.55
- Average True Range (ATR)
- KTTA 0.06
- GRABW 0.05
- MACD
- KTTA -0.01
- GRABW 0.02
- Stochastic Oscillator
- KTTA 9.32
- GRABW 69.54
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.